Trump admin eases access to unproven peptides favored by RFK Jr. despite FDA opposition

Trump admin eases access to unproven peptides favored by RFK Jr. despite FDA opposition

WASHINGTON — The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. Food and Drug Administration scientific staffers had little input on the decision and opposed the changes, according to six people familiar with its development. The draft policy posted online by Kennedy’s Department … Read more

Low testosterone crisis in American men could lead to security threats, Trump admin warns

Low testosterone crisis in American men could lead to security threats, Trump admin warns

The Trump administration is targeting testosterone deficiency as a potential threat to military readiness, rolling out new screening guidelines for male service members amid growing concerns about the health of American men and the shrinking pool of young people qualified to serve. “There is absolutely national defense readiness ramifications for [low testosterone],” Adm. Brian Christine, … Read more

Trump admin seeks to roll back testosterone restrictions — why docs are conflicted

Trump admin seeks to roll back testosterone restrictions — why docs are conflicted

It may soon get easier for older men to get ahold of testosterone therapy. On Thursday, the Department of Health and Human Services (HHS) announced that it is requesting updates to the prescribing information testosterone replacement therapy drugs, or TRT. The department is hoping to roll back restrictions on access for older men — but not … Read more

Trump admin strikes zero tariff pharmaceutical deal with Britain — a move welcomed by drugmakers

Trump admin strikes zero tariff pharmaceutical deal with Britain — a move welcomed by drugmakers

 The United States and Britain announced a deal on Monday to secure zero tariffs on British pharmaceutical products and medical technology in return for Britain spending more on medicines and overhauling how it values drugs. Under the agreement, Britain will raise the net price it pays for new US medicines by 25%. In return, UK-made medicines, drug ingredients and medical technology will be exempt … Read more